Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease

NCT02496884 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia

Interventions

DRUG: DS-5565
DRUG: Placebo

Sponsor

Daiichi Sankyo

Collaborators

[object Object]